Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04634825 |
| Consolidated Lead Sponsor | MacroGenics |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 62 participants (ACTUAL) |
| Registered Start Date | 2021-03-17 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor, MI | Open Hospital Dossier -> |
| Comprehensive Cancer Centers of Nevada | Las Vegas, NV | Open Hospital Dossier -> |
| University of Pennsylvania Abramson Cancer Center | Philadelphia, PA | Open Hospital Dossier -> |
| Liverpool Hospital | Liverpool, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.